Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 848-854

  Karakitsos, Dimitrios ^a   Papanikolaou, John ^b   Karabinis, Andreas ^a   Alalawi, Raed ^c   Wachtel, Mitchell ^c   Jumper, Cynthia ^c   Alexopoulos, Dimitrios ^d   Davlouros, Periklis ^d  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Dobutamine; PH; Pulmonary disease; RV failure; Sildenafil

Indexed keywords

DOBUTAMINE; PROPOFOL; REMIFENTANIL; SILDENAFIL;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOVASCULAR PARAMETERS; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; INVASIVE PROCEDURE; LOW DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; MEAN PULMONARY ARTERY PRESSURE; NASOGASTRIC TUBE; OUTCOME ASSESSMENT; OXYGENATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; PULMONARY VASCULAR RESISTANCE INDEX; RIGHT VENTRICLE STROKE WORK INDEX; SEDATION; TREATMENT FAILURE; TREATMENT RESPONSE; WEANING; WORLD HEALTH ORGANIZATION;

DOBUTAMINE; PH; PULMONARY DISEASE; RV FAILURE; SILDENAFIL;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; DOBUTAMINE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PURINES; RESPIRATION, ARTIFICIAL; SULFONES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84880918945     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.02.006     Document Type: Article

References (32)

1. G. Simonneau, N. Galie, and L.J. Rubin Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 2004 5S 12S
2. M.K. Han, V.V. McLaughlin, G.J. Criner, and F.J. Martinez Pulmonary diseases and the heart Circulation 116 2007 2992 3005
3. B.C. Morgan, E.W. Crawford, and W.G. Guntheroth The hemodynamic effects of changes in blood volume during intermittent positive-pressure ventilation Anesthesiology 30 1969 297 305
4. N.F. Voelkel, R.A. Quaife, and L.A. Leinwand Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure Circulation 114 2006 1883 1891
5. G. Piazza, and S.Z. Goldhaber The acutely decompensated right ventricle: pathways for diagnosis and management Chest 128 2005 1836 1852
6. A. Mebazaa, P. Karpati, E. Renaud, and L. Algotsson Acute right ventricular failure - from pathophysiology to new treatments Intensive Care Med 30 2004 185 196
7. F. Kerbaul, B. Rondelet, and J.P. Demester Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure Crit Care Med 34 2006 2814 2819
8. J. Nagendran, S.L. Archer, and D. Soliman Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility Circulation 116 2007 238 248
9. E.D. Michelakis The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension Heart Fail Rev 8 2003 5 21
10. N. Garg, M.K. Sharma, and N. Sinha Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship Int J Cardiol 120 2007 306 313
11. A. Chockalingam, G. Gnanavelu, and S. Venkatesan Efficacy and optimal dose of sildenafil in primary pulmonary hypertension Int J Cardiol 99 2005 91 95
12. P. Pokreisz, S. Vandenwijngaert, and V. Bito Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice Circulation 119 2009 408 416
13. N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
14. G. Jackson, N. Benjamin, N. Jackson, and M.J. Allen Effects of sildenafil citrate on human hemodynamics Am J Cardiol 83 1999 13C 20C
15. N.B. Schiller, P.M. Shah, and M. Crawford Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
16. F. Michard, D. Chemla, and C. Richard Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP Am J Respir Crit Care Med 159 1999 935 939
17. D. De Backer, S. Heenen, M. Piagnerelli, M. Koch, and J.L. Vincent Pulse pressure variations to predict fluid responsiveness: influence of tidal volume Intensive Care Med 31 2005 517 523
18. S. Kaul, C. Tei, J.M. Hopkins, and P.M. Shah Assessment of right ventricular function using two-dimensional echocardiography Am Heart J 107 1984 526 531
19. D. Miller, M.G. Farah, A. Liner, K. Fox, M. Schluchter, and B.D. Hoit The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance J Am Soc Echocardiogr 17 2004 443 447
20. H.K. Kim, Y.J. Kim, and J.S. Park Determinants of the severity of functional tricuspid regurgitation Am J Cardiol 98 2006 236 242
21. N. Rajagopalan, M.A. Simon, M.A. Mathier, and A. Lopez-Candales Identifying right ventricular dysfunction with tissue Doppler imaging in pulmonary hypertension Int J Cardiol 128 2008 359 363
22. S.L. Archer, K.A. Freude, and P.J. Shultz Effect of graded hypoxia on the induction and function of inducible nitric oxide synthase in rat mesangial cells Circ Res 77 1995 21 28
23. J. Qin, and B. Zhang Best combination of multiple diagnostic tests for screening purposes Stat Med. 29 2010 2905 2919
24. A. Pagnamenta, P. Fesler, A. Vandinivit, S. Brimioulle, and R. Naeije Pulmonary vascular effects of dobutamine in experimental pulmonary hypertension Crit Care Med 31 2003 1140 1146
25. F. Kerbaul, B. Rondelet, and S. Motte Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure Crit Care Med 32 2004 1035 1040
26. K.K. Bradford, B. Deb, and R.G. Pearl Combination therapy with inhaled nitric oxide and intravenous dobutamine during pulmonary hypertension in the rabbit J Cardiovasc Pharmacol 36 2000 146 151
27. E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, and S. Archer Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide Circulation 105 2002 2398 2403
28. R.M. Wallis, J.D. Corbin, S.H. Francis, and P. Ellis Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro Am J Cardiol 83 1999 3C 12C
29. A. Andersen, J.M. Nielsen, C.D. Peters, U.K. Schou, E. Sloth, and J.E. Nielsen-Kudsk Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart Eur J Heart Fail 10 2008 1158 1165
30. M. Guazzi, M. Samaja, R. Arena, M. Vicenzi, and M.D. Guazzi Long-term use of sildenafil in the therapeutic management of heart failure J Am Coll Cardiol 50 2007 2136 2144
31. M. Acikel, M. Yilmaz, and Y. Gurlertop The effect of pulmonary hypertension on left atrial mechanical functions in chronic obstructive lung disease Int J Cardiol 97 2004 187 192
32. I. Blanco, E. Gimeno, P.A. Munoz, S. Pizarro, C. Gistau, and R. Rodriguez-Roisin Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension Am J Respir Crit Care Med. 181 2010 270 278